BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27894923)

  • 1. Therapeutic implications of toll-like receptors in peripheral neuropathic pain.
    Thakur KK; Saini J; Mahajan K; Singh D; Jayswal DP; Mishra S; Bishayee A; Sethi G; Kunnumakkara AB
    Pharmacol Res; 2017 Jan; 115():224-232. PubMed ID: 27894923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors in peripheral nerve injury and neuropathic pain.
    Kim D; Lee S; Lee SJ
    Curr Top Microbiol Immunol; 2009; 336():169-86. PubMed ID: 19688334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain.
    Longhi-Balbinot DT; Rossaneis AC; Pinho-Ribeiro FA; Bertozzi MM; Cunha FQ; Alves-Filho JC; Cunha TM; Peron JP; Miranda KM; Casagrande R; Verri WA
    Chem Biol Interact; 2016 Aug; 256():1-8. PubMed ID: 27287419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated microglia in the spinal cord underlies diabetic neuropathic pain.
    Wang D; Couture R; Hong Y
    Eur J Pharmacol; 2014 Apr; 728():59-66. PubMed ID: 24508519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain.
    Mei XP; Zhou Y; Wang W; Tang J; Wang W; Zhang H; Xu LX; Li YQ
    Neurosignals; 2011; 19(1):44-53. PubMed ID: 21389680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of neuropathic pain: mode of action of anticonvulsants.
    Dickenson AH; Matthews EA; Suzuki R
    Eur J Pain; 2002; 6 Suppl A():51-60. PubMed ID: 11888242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide prevents and attenuates neuropathic pain via inhibiting central immune response.
    Wang W; Mei XP; Chen L; Tang J; Li JL; Wu SX; Xu LX; Li YQ
    Pain Physician; 2012; 15(6):E995-1006. PubMed ID: 23159984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic Mechanisms of Antidepressants for Neuropathic Pain.
    Obata H
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.
    Guida F; Lattanzi R; Boccella S; Maftei D; Romano R; Marconi V; Balboni G; Salvadori S; Scafuro MA; de Novellis V; Negri L; Maione S; Luongo L
    Pharmacol Res; 2015 Jan; 91():36-46. PubMed ID: 25434589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord.
    Heiman A; Pallottie A; Heary RF; Elkabes S
    Brain Behav Immun; 2014 Nov; 42():232-45. PubMed ID: 25063708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal astrocytic c-Jun N-terminal kinase (JNK) activation as counteracting mechanism to the amitriptyline analgesic efficacy in painful peripheral neuropathies.
    Sanna MD; Ghelardini C; Galeotti N
    Eur J Pharmacol; 2017 Mar; 798():85-93. PubMed ID: 28119076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-HT receptors in neuropathic pain: potential therapeutic implications.
    Liu QQ; Yao XX; Gao SH; Li R; Li BJ; Yang W; Cui RJ
    Pharmacol Res; 2020 Sep; 159():104949. PubMed ID: 32464329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Central Analgesic Mechanism of YM-58483 in Attenuating Neuropathic Pain in Rats.
    Qi Z; Wang Y; Zhou H; Liang N; Yang L; Liu L; Zhang W
    Cell Mol Neurobiol; 2016 Oct; 36(7):1035-43. PubMed ID: 26514127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic effects and possible mechanisms of iridoid glycosides from Lamiophlomis rotata (Benth.) Kudo in rats with spared nerve injury.
    Zheng Y; Yin X; Huo F; Xiong H; Mei Z
    J Ethnopharmacol; 2015 Sep; 173():204-11. PubMed ID: 26160748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors and their role in neuropathic pain and migraine.
    Liu X; Yang W; Zhu C; Sun S; Wu S; Wang L; Wang Y; Ge Z
    Mol Brain; 2022 Aug; 15(1):73. PubMed ID: 35987639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
    Velasco M; O'Sullivan C; Sheridan GK
    Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights.
    Kremer M; Salvat E; Muller A; Yalcin I; Barrot M
    Neuroscience; 2016 Dec; 338():183-206. PubMed ID: 27401055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
    Zhou C; Shi X; Huang H; Zhu Y; Wu Y
    Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain.
    Tatsumi E; Yamanaka H; Kobayashi K; Yagi H; Sakagami M; Noguchi K
    Glia; 2015 Feb; 63(2):216-28. PubMed ID: 25130721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
    Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.